小鼠模型市場：按模型類型、按服務、按技術、按應用、按最終用戶、按地區

預計 2025 年小鼠模型市場價值將達到 18.6 億美元，到 2032 年預計將達到 36 億美元，2025 年至 2032 年的年複合成長率（CAGR）為 9.9%。

全球小鼠模型市場在更廣泛的生物醫學研究生態系統中佔有重要的地位，是科學發現和藥物開發的重要工具。實驗室小鼠，尤其是基因轉殖小鼠，由於其與人類基因相似、生物系統特徵明確、研究通訊協定成熟，已成為臨床前研究的黃金標準。該市場涵蓋各種小鼠模型，包括近交系和遠交系、基因工程模型小鼠 (GEM) 和免疫力缺乏小鼠，每種模型都旨在複製特定的人類疾病和病症。

慢性病、癌症、神經系統疾病和代謝性疾病的增多，推動了對能夠準確模擬人類病理生理的先進動物模型的需求。學術機構、製藥公司、生技公司和受託研究機構都高度依賴這些模型進行藥物研發、毒理學研究、療效測試和個人化醫療研究。 CRISPR-Cas9 等基因工程技術的進步進一步推動了市場成長。 CRISPR-Cas9 能夠開發更精準、特異性疾病的小鼠模型，進而改善研究成果，並加速實驗室研究成果向臨床應用的轉化。

市場動態

全球小鼠模型市場的成長受到多種誘人因素的驅動，這些因素推動了其在製藥和生物技術領域的強勁擴張。首先是藥物研發活動的指數級成長，藥廠越來越依賴複雜的小鼠模型來評估治療方案的有效性和安全性，然後再進行人體試驗。癌症、糖尿病、心血管疾病和神經系統疾病等慢性疾病的發生率上升，使得開發能夠準確重現人類病理生理學的疾病特異性小鼠模型成為必要，從而推動了市場需求。

此外，基因工程技術的進步，尤其是 CRISPR-Cas9 和其他基因編輯技術的進步，徹底改變了基因轉殖小鼠模型的創建，使研究人員能夠開發出更精確、更有針對性的實驗系統。然而，該市場面臨重大限制因素，威脅其成長軌跡。嚴格的動物研究法律規範，包括倫理考量和合規要求，為市場擴張設置了障礙，並增加了研究機構的營運成本。對體外模型、器官晶片技術和計算建模等替代測試方法的日益重視，對傳統的基於動物的研究模式構成了潛在威脅。此外，培育、維護和飼養特定小鼠品系的高成本，加上對專門設施和訓練有素的人員的需求，限制了小型研究機構獲得此類研究的便利性。

儘管面臨諸多挑戰，個人化醫療方法的日益普及（這種方法需要患者特定的小鼠模型來開發客製化治療方案）正在創造巨大的商機。提供專業小鼠模型服務的受託研究機構的擴張為市場成長提供了有利機會，尤其是在研究基礎設施快速發展的新興市場。

本次調查的主要特點

• 本報告對全球小鼠模型市場進行了詳細分析，並以 2024 年為基準年，給出了預測期（2025-2032 年）的市場規模（十億美元）和年複合成長率（CAGR%）。
• 它還強調了各個領域的潛在商機，並說明了針對該市場的引人注目的投資提案。
• 它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景以及主要企業採用的競爭策略的重要見解。
• 它根據公司亮點、產品系列、關鍵亮點、性能和策略等參數，概述了全球小鼠模型市場的主要企業。
• 本報告的見解將使負責人和公司經營團隊能夠就未來的產品發布、類型升級、市場擴張和行銷策略做出明智的決策。
• 本研究報告針對該產業的各個相關人員，包括投資者、供應商、產品製造商、經銷商、新進業者和財務分析師。
• 透過用於分析全球小鼠模型市場的各種策略矩陣，相關人員將更容易做出決策。

目錄

第 1 章：調查目標與先決條件

• 調查目的
• 先決條件
• 簡稱

第2章 市場展望

• 報告描述
  • 市場定義和範圍
• 執行摘要

第3章：市場動態、法規與趨勢分析

• 市場動態
• 驅動程式
• 抑制因素
• 機會
• 影響分析
• 主要進展
• 監管情景
• 產品發布/核准
• PEST分析
• 波特分析
• 併購場景
• 產業趨勢

4. 2020 年至 2032 年全球小鼠模型市場（依模型類型）

• 基因工程小鼠（GEM）
• 近交系小鼠
• 雜交小鼠品系
• 雜交/同源小鼠
• 自發突變小鼠

5. 2020-2032 年全球小鼠模型市場（按服務分類）

• 育種服務
• 冷凍保存、重新交付和定序服務
• 基因檢測與表徵服務
• 體內和體外模型服務
• 客製化模型開發服務

6. 2020-2032 年全球小鼠模型市場（依技術分類）

• CRISPR/Cas9
• 胚胎幹細胞（ESC）技術
• 核子移植技術
• 顯微注射技術
• 其他（例如 TALEN、ZFN）

7. 2020 年至 2032 年全球小鼠模型市場（按應用）

• 腫瘤學研究
• 免疫學/發炎研究
• 糖尿病研究
• 心血管研究
• 神經疾病研究
• 罕見疾病研究
• 毒性與安全性評估
• 其他（例如代謝紊亂、感染疾病）

8. 全球小鼠模型市場（依最終用戶分類），2020-2032 年

• 製藥和生物技術公司
• 學術和研究機構
• 合約研究組織（CRO）
• 政府機構和非營利組織

9. 2020-2032 年全球小鼠模型市場（按地區）

• 北美洲
  • 美國
  • 加拿大
• 拉丁美洲
  • 巴西
  • 阿根廷
  • 墨西哥
  • 其他拉丁美洲
• 歐洲
  • 德國
  • 英國
  • 西班牙
  • 法國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國
  • ASEAN
  • 其他亞太地區
• 中東
  • 海灣合作理事會國家
  • 以色列
  • 其他中東地區
• 非洲
  • 南非
  • 北非
  • 中部非洲

第10章 競爭格局

• Charles River Laboratories
• The Jackson Laboratory
• Inotiv
• genOway
• Taconic Biosciences
• Janvier Labs
• Crown Bioscience
• Cyagen Biosciences
• GemPharmatech
• Shanghai Model Organisms Center（SMOC）
• Biocytogen
• Ozgene Pty Ltd
• Trans Genic Inc.
• Harbour BioMed
• JSR Life Sciences

第 11 章分析師建議

• 機會
• 分析師觀點
• Coherent Opportunity Map

第12章參考文獻與調查方法

• 參考
• 調查方法
• 關於出版商

Mice Model Market is estimated to be valued at USD 1.86 Bn in 2025 and is expected to reach USD 3.60 Bn by 2032, growing at a compound annual growth rate (CAGR) of 9.9% from 2025 to 2032.

The global mice model market represents a critical segment within the broader biomedical research ecosystem, serving as an indispensable tool for scientific discovery and pharmaceutical development. Laboratory mice, particularly genetically modified strains, have become the gold standard for preclinical research due to their genetic similarity to humans, well-characterized biological systems, and established research protocols. This market encompasses various mouse models including inbred strains, outbred stocks, Genetically Engineered Models (GEMs), and immunodeficient mice, each designed to replicate specific human diseases and conditions.

The increasing prevalence of chronic diseases, cancer, neurological disorders, and metabolic conditions has intensified the demand for sophisticated animal models that can accurately mimic human pathophysiology. Academic institutions, pharmaceutical companies, biotechnology firms, and contract research organizations heavily rely on these models for drug discovery, toxicology studies, efficacy testing, and personalized medicine research. The market's growth is further propelled by technological advancements in genetic engineering techniques such as CRISPR-Cas9, which enable the development of more precise and disease-specific mouse models, thereby enhancing research outcomes and accelerating the translation of laboratory findings into clinical applications.

Market Dynamics

The global mice model market growth is driven by several compelling factors that collectively fuel its robust expansion across the pharmaceutical and biotechnology sectors. The primary driver stems from the exponential growth in drug discovery and development activities, where pharmaceutical companies increasingly rely on sophisticated mouse models to evaluate therapeutic efficacy and safety profiles before advancing to human trials. The rising prevalence of chronic diseases, including cancer, diabetes, cardiovascular disorders, and neurological conditions, necessitates the development of disease-specific mouse models that can accurately replicate human pathophysiology, thereby driving market demand.

Additionally, technological advancements in genetic engineering, particularly CRISPR-Cas9 and other gene-editing technologies, have revolutionized the creation of genetically modified mouse models, enabling researchers to develop more precise and targeted experimental systems. However, the market faces significant restraints that challenge its growth trajectory. Stringent regulatory frameworks governing animal research, including ethical considerations and compliance requirements, create barriers for market expansion and increase operational costs for research institutions. The growing emphasis on alternative testing methods, such as in-vitro models, organ-on-chip technologies, and computational modeling, poses a potential threat to traditional animal-based research paradigms. Furthermore, the high costs associated with breeding, maintaining, and housing specialized mouse strains, coupled with the need for specialized facilities and trained personnel, limit accessibility for smaller research organizations.

Despite these challenges, substantial opportunities emerge from the increasing adoption of personalized medicine approaches, which require patient-specific mouse models for tailored therapeutic development. The expansion of contract research organizations offering specialized mouse model services presents lucrative opportunities for market growth, particularly in emerging markets where research infrastructure is rapidly developing.

Key Features of the Study

• This report provides in-depth analysis of the global mice model market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global mice model market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Charles River Laboratories, The Jackson Laboratory, Inotiv, genOway, Taconic Biosciences, Janvier Labs, Crown Bioscience, Cyagen Biosciences, GemPharmatech, Shanghai Model Organisms Center (SMOC), Biocytogen, Ozgene Pty Ltd, Trans Genic Inc., Harbour BioMed, and JSR Life Sciences
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global mice model market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global mice model market

Market Segmentation

• Model Type Insights (Revenue, USD Bn, 2020 - 2032)
  • Genetically Engineered Mice (GEM)
  • Knockout Mice
  • Knock-in Mice
  • Conditional Mutant Mice
  • Inbred Mice
  • Outbred Mice
  • Hybrid/Congenic Mice
  • Spontaneous Mutant Mice
• Service Insights (Revenue, USD Bn, 2020 - 2032)
  • Breeding Services
  • Cryopreservation, Rederivation, and Resequencing Services
  • Genetic Testing and Characterization Services
  • Model In-vivo and In-vitro Testing Services
  • Custom Model Development Services
• Technology Insights (Revenue, USD Bn, 2020 - 2032)
  • CRISPR/Cas9
  • Embryonic Stem Cell (ESC) Technology
  • Nuclear Transfer Technology
  • Microinjection Technology
  • Others (e.g., TALENs, ZFNs)
• Application Insights (Revenue, USD Bn, 2020 - 2032)
  • Oncology Research
  • Immunology and Inflammation Studies
  • Diabetes Research
  • Cardiovascular Research
  • Neurological Disease Research
  • Rare Disease Research
  • Toxicology and Safety Assessment
  • Others (e.g., Metabolic Disorders, Infectious Diseases)
• End User Insights (Revenue, USD Bn, 2020 - 2032)
  • Pharmaceutical and Biotechnology Companies
  • Academic and Research Institutions
  • Contract Research Organizations (CROs)
  • Government and Nonprofit Organizations
• Regional Insights (Revenue, USD Bn, 2020 - 2032)
  • North America
  • U.S.
  • Canada
  • Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Europe
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • GCC Countries
  • Israel
  • Rest of Middle East
  • Africa
  • South Africa
  • North Africa
  • Central Africa
• Key Players Insights
  • Charles River Laboratories
  • The Jackson Laboratory
  • Inotiv
  • genOway
  • Taconic Biosciences, Inc.
  • Janvier Labs
  • Crown Bioscience
  • Cyagen
  • GemPharmatech
  • Shanghai Model Organisms Center, Inc.
  • Biocytogen
  • Ozgene Pty Ltd
  • Trans Genic Inc.
  • Harbour BioMed
  • JSR Life Sciences, LLC

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Global Mice Model Market, By Model Type
  • Global Mice Model Market, By Service
  • Global Mice Model Market, By Technology
  • Global Mice Model Market, By Application
  • Global Mice Model Market, By End User
  • Global Mice Model Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
• Driver
• Restraint
• Opportunity
• Impact Analysis
• Key Developments
• Regulatory Scenario
• Product Launches/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario
• Industry Trends

4. Global Mice Model Market, By Model Type, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Genetically Engineered Mice (GEM)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
    • Knockout Mice
    • Knock-in Mice
    • Conditional Mutant Mice
• Inbred Mice
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Outbred Mice
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Hybrid/Congenic Mice
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Spontaneous Mutant Mice
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

5. Global Mice Model Market, By Service, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Breeding Services
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Cryopreservation, Rederivation, and Resequencing Services
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Genetic Testing and Characterization Services
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Model In-vivo and In-vitro Testing Services
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Custom Model Development Services
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Mice Model Market, By Technology, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• CRISPR/Cas9
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Embryonic Stem Cell (ESC) Technology
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Nuclear Transfer Technology
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Microinjection Technology
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Others (e.g., TALENs, ZFNs)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Mice Model Market, By Application, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Oncology Research
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Immunology and Inflammation Studies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Diabetes Research
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Cardiovascular Research
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Neurological Disease Research
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Rare Disease Research
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Toxicology and Safety Assessment
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Others (e.g., Metabolic Disorders, Infectious Diseases)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Mice Model Market, By End User, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Pharmaceutical and Biotechnology Companies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Academic and Research Institutions
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Contract Research Organizations (CROs)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Government and Nonprofit Organizations
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

9. Global Mice Model Market, By Region, 2020 - 2032, Value (USD Bn)

• Introduction
  • Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Bn)
  • Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Bn)
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, By Model Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Service, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, By Model Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Service, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, By Model Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Service, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, By Model Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Service, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, By Model Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Service, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • GCC Countries
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, By Model Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Service, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Bn)
    • South Africa
    • North Africa
    • Central Africa

10. Competitive Landscape

• Charles River Laboratories
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• The Jackson Laboratory
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Inotiv
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• genOway
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Taconic Biosciences
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Janvier Labs
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Crown Bioscience
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Cyagen Biosciences
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• GemPharmatech
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Shanghai Model Organisms Center (SMOC)
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Biocytogen
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Ozgene Pty Ltd
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Trans Genic Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Harbour BioMed
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• JSR Life Sciences
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies

11. Analyst Recommendations

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

12. References and Research Methodology

• References
• Research Methodology
• About us